BI
PAVM icon

Binnacle Investments’s PAVmed PAVM Stock Holding History

Binnacle Investments’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$29 Buy
+2
New +$30 ﹤0.01% 938
2025
Q2 		– Sell
-2
Closed -$48 – 833
2025
Q1 		$48 Buy
+2
New +$41 ﹤0.01% 779

Other funds holding PAVM

SWGC
Summit Wealth Group (Colorado) Colorado Springs, Colorado $1.21B AUM 33.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Binnacle Investments's PAVM Position: Q3 2025 in Review

Binnacle Investments opened a new position in PAVmed (PAVM) in Q3 2025: 2 shares worth $29. The stake represents ﹤0.01% of the portfolio and ranks #938 among its holdings. This is a return to the name: Binnacle Investments previously reported a position in PAVM as recently as Q1 2025.

Binnacle Investments first reported a position in PAVM in Q1 2025 and has held it in 2 quarters since. The position peaked at $48 in Q1 2025. 32 funds tracked by Wall St. Rank hold PAVM as of Q3 2025.

  • Binnacle Investments held 2 shares of PAVmed worth $29 as of Q3 2025.
  • PAVmed was a new Binnacle Investments position in Q3 2025.
  • PAVmed made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #938 holding.
  • Binnacle Investments first reported a position in PAVmed in Q1 2025 and has held it in 2 quarters since.
  • Binnacle Investments's PAVmed position peaked at $48 in Q1 2025.
  • 32 funds tracked by Wall St. Rank held PAVmed as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.